EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Impact of placental and peripheral blood DNA methylation on celiac disease susceptibility

Alba Hernangomez-Laderas, Ariadna Cilleros-Portet iD, Mikel de la Peña-Sanz, Sergi Marí iD, Corina Lesseur iD, Itziar González-Moro iD, Bárbara P González-García iD, Jia Chen, Iraia García-Santisteban iD, Carmen J Marsit iD, Jose Ramon Bilbao iD, Nora Fernandez-Jimenez iD

Journal of Pediatric Gastroenterology and Nutrition · 2025-09 · 81 (3) · 587-595

DOI: 10.1002/jpn3.70124 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Pediatric Gastroenterology and Nutrition, online erschienen am 22.06.2025. Verfasst von Alba Hernangomez-Laderas und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Genetics, Physical Anthropology and Animal Physiology, Biobizkaia Health Research Institute and University of the Basque Country (UPV/E…. Hauptthemen laut MEDLINE: Celiac Disease, DNA Methylation, Placenta, Genetic Predisposition to Disease. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 32 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: University of the Basque Country, NICHD NIH HHS, NIEHS NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objectives

Several studies suggest that the first immunogenic insult in celiac disease (CeD) could occur during fetal development. The placenta is a key organ that could link the environment with the genome and future outcomes, including CeD. Our objective is to determine the involvement of placental DNA methylation (DNAm) as potential mediator of the genetic susceptibility to CeD.

Methods

We used Summary‐data‐based Mendelian Randomization to infer what part of the susceptibility to CeD acts through DNAm in placenta or peripheral blood. We interrogated whether DNAm of the CpGs identified correlated with the expression of adjacent genes in the same tissues, and repeated the procedure only in cases and controls carrying the HLA‐DQ2 risk haplotype.

Results

We identified 248 and 215 CpGs associated with CeD in placenta and blood, respectively. Among the former, the DNAm of seven CpGs correlated with the placental expression of ZFP57 . In contrast, in the latter group, the most represented gene was RNF5 , with DNAm of 11 CpGs correlating with its expression in blood. In HLA‐DQ2 positive individuals, we observed a decrease of placental CpGs associated with CeD, with a remarkable exception in chromosome 2, close to AHSA2 . In blood, we identified 44 CpGs associated with CeD in the HLA region, with HLA‐DPA1 showing the largest number of DNAm‐expression associations.

Conclusions

Our results suggest that placenta does not seem to be a crucial effector in CeD, and show potentially causal relationships between blood DNAm and CeD, with independent signals in the HLA, and particularly in the HLA‐DPA1 gene.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Celiac DiseaseDNA MethylationPlacentaGenetic Predisposition to DiseaseHumansFemalePregnancyHLA-DQ AntigensCpG IslandsMendelian Randomization AnalysisCase-Control Studies

Stichwörter der Autor:innen

HLA regioncomplex diseasesgene expressiongenetic predisposition

Substanzen

HLA-DQ AntigensHLA-DQ2 antigen

Autor:innen und Institutionen

  • Department of Genetics, Physical Anthropology and Animal Physiology, Biobizkaia Health Research Institute and University of the Basque Country (UPV/EHU), Leioa, Spain.
  • Department of Environmental Medicine and Climate Science, Icahn School of Medicine at Mount Sinai, New York, New York, USA.
  • Gangarosa Department of Environmental Health, Rollins School of Public Health, Emory University, Atlanta, Georgia, USA.

ORCID-Profile: Ariadna Cilleros-Portet, Sergi Marí, Corina Lesseur, Itziar González-Moro, Bárbara P González-García, Iraia García-Santisteban, Carmen J Marsit, Jose Ramon Bilbao, Nora Fernandez-Jimenez

Förderung

  • University of the Basque Country
  • NICHD NIH HHS
  • NIEHS NIH HHS
  • Health Department of the Basque Country
  • MCIN/AEI/10.13039/501100011033
  • Mexican National Council for Science and Technology
  • U.S. National Institutes of Health
  • ESF Investing in Your Future

Zitieren

APA

Hernangomez-Laderas, A., Cilleros-Portet, A., de la Peña-Sanz, M., Marí, S., Lesseur, C., González-Moro, I., González-García, B. P., Chen, J., García-Santisteban, I., Marsit, C. J., Bilbao, J. R., & Fernandez-Jimenez, N. (2025). Impact of placental and peripheral blood DNA methylation on celiac disease susceptibility. Journal of Pediatric Gastroenterology and Nutrition, 81(3), 587-595. https://doi.org/10.1002/jpn3.70124

Vancouver

Hernangomez-Laderas A, Cilleros-Portet A, de la Peña-Sanz M, Marí S, Lesseur C, González-Moro I, et al. Impact of placental and peripheral blood DNA methylation on celiac disease susceptibility. Journal of Pediatric Gastroenterology and Nutrition. 2025;81(3):587-595. doi:10.1002/jpn3.70124

BibTeX
@article{HernangomezLaderas2025,
  author = {Hernangomez-Laderas, Alba and Cilleros-Portet, Ariadna and de la Peña-Sanz, Mikel and Marí, Sergi and Lesseur, Corina and González-Moro, Itziar and González-García, Bárbara P and Chen, Jia and García-Santisteban, Iraia and Marsit, Carmen J and Bilbao, Jose Ramon and Fernandez-Jimenez, Nora},
  title = {Impact of placental and peripheral blood DNA methylation on celiac disease susceptibility},
  journal = {Journal of Pediatric Gastroenterology and Nutrition},
  year = {2025},
  volume = {81},
  number = {3},
  pages = {587--595},
  doi = {10.1002/jpn3.70124}
}
Kostenlos starten →